MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $981,668 | +127721.4% | 22,536 | +6.0% | 0.06% | +37.0% |
Q2 2023 | $768 | -3.0% | 21,252 | -0.2% | 0.05% | -6.1% |
Q1 2023 | $792 | -11.5% | 21,299 | +7.8% | 0.05% | -10.9% |
Q4 2022 | $895 | -99.9% | 19,763 | +111.9% | 0.06% | +27.9% |
Q3 2022 | $651,000 | +38.5% | 9,327 | +33.2% | 0.04% | +48.3% |
Q2 2022 | $470,000 | -68.7% | 7,001 | -17.4% | 0.03% | -63.3% |
Q3 2021 | $1,500,000 | -17.5% | 8,478 | -24.7% | 0.08% | -18.6% |
Q2 2021 | $1,819,000 | -58.2% | 11,260 | -55.7% | 0.10% | -62.8% |
Q1 2021 | $4,350,000 | – | 25,394 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |